Health in Saudi Arabia

Applied BioSciences Begins Offering Coronavirus Test Kit to the General Public to Combat Spread of COVID-19

Retrieved on: 
Tuesday, March 31, 2020

These Coronavirus Test Kits are CE certified, accurate, affordable and reliable results in under 15 minutes.

Key Points: 
  • These Coronavirus Test Kits are CE certified, accurate, affordable and reliable results in under 15 minutes.
  • The IgM and IgG Rapid Coronavirus SARS COVID-19 nCoV Test Kit has been widely used by the Chinese Government to detect infections and is now available globally.
  • This is an expansion of products that will help battle the spread of the coronavirus ("COVID-19").
  • The team at Applied BioSciences is prioritizing the development of additional products to help battle the spread of the COVID-19.

CAVCO INDUSTRIES PROVIDES BUSINESS UPDATE ON CORONAVIRUS (COVID-19) PANDEMIC

Retrieved on: 
Tuesday, March 31, 2020

PHOENIX, March 30, 2020 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) today provided a business and operations update regarding the novel coronavirus COVID-19 ("COVID-19") pandemic.

Key Points: 
  • PHOENIX, March 30, 2020 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) today provided a business and operations update regarding the novel coronavirus COVID-19 ("COVID-19") pandemic.
  • Cavco Industries, Inc., headquartered in Phoenix, Arizona, designs and produces factory-built housing products primarily distributed through a network of independent and Company-owned retailers.
  • It will depend on the duration of the pandemic, its geographic spread, potential business disruptions and the overall impact on the national economy and consumer behavior.
  • Cavco expressly disclaims any obligation to update any forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

Todos Medical Expands on Coronavirus (COVID-19) Distribution Agreement with Shanghai Liangrun Subsidiary Gibraltar

Retrieved on: 
Monday, March 30, 2020

Dr. Joseph Wee, CEO of Todos subsidiary Todos Medical Singapore Pte Ltd., will be responsible for the commercialization effort inAsia.

Key Points: 
  • Dr. Joseph Wee, CEO of Todos subsidiary Todos Medical Singapore Pte Ltd., will be responsible for the commercialization effort inAsia.
  • I am very pleased to lead the effort to bring point-of-care and additional PCR antibody testing to the Asian market, said Dr. Joseph Wee, CEO of Todos Medical Singapore Ltd.
  • Headquartered in Rehovot, Israel, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers.
  • Todos recently entered into distribution agreements with China-based companies to distribute certain novel coronavirus (COVID-19) test kits.

Rendu Gets NMPA's Emergency Approval For Coronavirus Nucleic Acid Detection System

Retrieved on: 
Monday, March 30, 2020

SHANGHAI, March 30, 2020 /PRNewswire/ -- Rendu Biotechnology today announces that China's National Medical Products Administration (NMPA) has granted emergency approval to Rendu's coronavirus 2019-nCoV nucleic acid detection kit (hereinafter referred to as "2019-nCoV detection kit").

Key Points: 
  • SHANGHAI, March 30, 2020 /PRNewswire/ -- Rendu Biotechnology today announces that China's National Medical Products Administration (NMPA) has granted emergency approval to Rendu's coronavirus 2019-nCoV nucleic acid detection kit (hereinafter referred to as "2019-nCoV detection kit").
  • This is the only RNA capture probe nucleic acid detection kit that has been approved by the Chinese regulator so far.
  • In addition to the detection kit, Rendy also launched AutoSAT, a fully automatic, high-throughput, and full-process integrated platform for coronavirus nucleic acid detection.
  • As of March 27th, the NMPA has granted 23 emergency approvals to coronavirus detection products and eight antibody detection reagents.

Nippon Express' East Asia Region Launches BCP Solutions in Response to Logistics Restrictions Imposed in Wake of Novel Coronavirus Outbreak

Retrieved on: 
Monday, March 23, 2020

TOKYO, March 23, 2020 /PRNewswire/ -- The East Asia Region of Nippon Express Co., Ltd. has begun providing BCP solutions utilizing a full range of transport modes to cope with the various restrictions that have been imposed on logistics within China since the novel coronavirus outbreak began.

Key Points: 
  • TOKYO, March 23, 2020 /PRNewswire/ -- The East Asia Region of Nippon Express Co., Ltd. has begun providing BCP solutions utilizing a full range of transport modes to cope with the various restrictions that have been imposed on logistics within China since the novel coronavirus outbreak began.
  • The spread of novel coronavirus infections has seriously impeded logistics in China, with the number of flights to/from and within the country reduced substantially, restrictions placed on truck traffic between provinces/cities and restrictions imposed on loading/unloading cargo at international railway stations within China.
  • At the behest of its customers, Nippon Express provides BCP solutions by developing alternate routes and utilizing/combining various transport modes to help customers maintain their business operations.
  • "SEA&RAIL Service to/from Inland China Utilizing New International Land-Sea Trade Corridor (Eastbound Corridor, Southbound Corridor)"

Committee inquiries suspended due to coronavirus action

Retrieved on: 
Friday, March 20, 2020

The Committee has postponed the oral evidence hearings previously scheduled to the end of March, in line with guidance on reducing the spread of the novel coronavirus or Covid-19.

Key Points: 
  • The Committee has postponed the oral evidence hearings previously scheduled to the end of March, in line with guidance on reducing the spread of the novel coronavirus or Covid-19.
  • - have been suspended, we will provide updates on these as soon as possible.
  • Where the Committee has completed the oral evidence hearing stage of its inquiry , it is expected that it will proceed to produce a report and the Government publish its response in the usual way, although there may be some adjustment to the usual timelines.
  • We will update these pages with further information as soon as possible.

Committee inquiries suspended due to coronavirus action

Retrieved on: 
Friday, March 20, 2020

The Committee has postponed the oral evidence hearings previously scheduled to the end of March, in line with guidance on reducing the spread of the novel coronavirus or Covid-19.

Key Points: 
  • The Committee has postponed the oral evidence hearings previously scheduled to the end of March, in line with guidance on reducing the spread of the novel coronavirus or Covid-19.
  • - have been suspended, we will provide updates on these as soon as possible.
  • Where the Committee has completed the oral evidence hearing stage of its inquiry , it is expected that it will proceed to produce a report and the Government publish its response in the usual way, although there may be some adjustment to the usual timelines.
  • We will update these pages with further information as soon as possible.

Committee inquiries suspended due to coronavirus action

Retrieved on: 
Friday, March 20, 2020

The Committee has postponed the oral evidence hearings previously scheduled to the end of March, in line with guidance on reducing the spread of the novel coronavirus or Covid-19.

Key Points: 
  • The Committee has postponed the oral evidence hearings previously scheduled to the end of March, in line with guidance on reducing the spread of the novel coronavirus or Covid-19.
  • - have been suspended, we will provide updates on these as soon as possible.
  • Where the Committee has completed the oral evidence hearing stage of its inquiry , it is expected that it will proceed to produce a report and the Government publish its response in the usual way, although there may be some adjustment to the usual timelines.
  • We will update these pages with further information as soon as possible.

Mytonomy Releases 16 New Videos to Support Patient Education Efforts around Coronavirus

Retrieved on: 
Wednesday, March 18, 2020

BETHESDA, Md., March 18, 2020 /PRNewswire-PRWeb/ -- Mytonomy, an enterprise SaaS company and film studio enabling healthcare's digital front door, announced today the availability of 16 new videos in English and Spanish to support patient-facing education around the novel Coronavirus (SARS2-CoV-19).

Key Points: 
  • BETHESDA, Md., March 18, 2020 /PRNewswire-PRWeb/ -- Mytonomy, an enterprise SaaS company and film studio enabling healthcare's digital front door, announced today the availability of 16 new videos in English and Spanish to support patient-facing education around the novel Coronavirus (SARS2-CoV-19).
  • The company has been providing support to multiple health systems via the development of original content to support this rapidly evolving public health crisis.
  • "One of my favorite videos in this release is How Community Spread Happens Fast.
  • Coronavirus has forced us to think differently and do what we each can to help flatten the curve," said Kataria.

Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay

Retrieved on: 
Wednesday, March 18, 2020

EUAs allow for the early availability of important diagnostic tools when there are no adequate, approved and available alternatives.1

Key Points: 
  • EUAs allow for the early availability of important diagnostic tools when there are no adequate, approved and available alternatives.1
    The Lyra product line offers PCR reagent kits for use by molecular diagnostic laboratories with existing molecular testing infrastructure such as the Applied Biosystems 7500 Fast DX instruments.
  • These reagents include unique features that provide for simple transport and storage, improved workflow, shorter time to result, and other benefits that favorably affect diagnostic test outcome.
  • The Lyra SARS-CoV-2 Assay provides these and certain additional advantages over other tests currently on the market for this novel coronavirus, including easier setup and faster time to result.
  • Emergency Use Authorization for our Lyra SARS-CoV-2 Assay allows Quidel to join the global fight against the COVID-19 outbreak by providing healthcare workers in highly complex laboratories with a fast, accurate tool to diagnose patients infected with the novel coronavirus.